Dr. Stanley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4140 W. Memorial Rd
Ste 321
Oklahoma City, OK 73120Phone+1 405-748-4726Fax+1 405-607-8497
Education & Training
- Wake Forest University Baptist Medical CenterResidency, Obstetrics and Gynecology, 1992 - 1994
- ECU Health Medical Center/East Carolina UniversityInternship, Obstetrics and Gynecology, 1988 - 1992
- Vidant Medical CenterInternship, Transitional Year, 1987 - 1988
- University of Oklahoma College of MedicineClass of 1987
Certifications & Licensure
- AR State Medical License 2015 - 2025
- MO State Medical License 2019 - 2025
- OK State Medical License 1994 - 2025
- NC State Medical License 1988 - 1999
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Publications & Presentations
PubMed
- 15 citationsReduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetesYongxin Jeremy Yu, Kristian F. Hanssen, V. Kalyanaraman, A. Chirindel, Alicia J. Jenkins
BJOG. 2012-11-01 - 52 citationsAnti-angiogenic factors and pre-eclampsia in type 1 diabetic women.Yongxin Yu, Alicia J. Jenkins, Alison Nankervis, Kristian F. Hanssen, Hanne Scholz
Diabetologia. 2009-01-01 - 8 citationsEarly postpartum discharge at a university hospital. Outcome analysis.Bossert R, Rayburn Wf, Stanley, Coleman Fh, Mirabile Cl
The Journal of Reproductive Medicine. 2001-01-01
Press Mentions
- Oklahoma Sees Low COVID-19 Vaccination Rate Among Pregnant WomenOctober 7th, 2021
Grant Support
- High Throughput Screening To FIND Inhibitors Of Pathogenic Pemphigus AntibodiesNational Institute On Drug Abuse2011–2012
- Determine Whether An Anti-Dsg3 Single Chain Variable Fragment Antibody (SCFV) - PNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011
- Core CenterNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011
- Cloning And Genetics Of Human Pemphigus AutoantibodiesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2011
- Mechanisms Of Blister Formation By Staphylococcal ToxinsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2006
- Dermatology Research Training GrantNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2004
- Pathogenesis Of PemphigusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2001
- Function Of Pemphigus Vulgaris AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: